R95 Admission Policy (2-A) – only for agencies that DID NOT participate in FY23-24
Designed to ensure more flexible admission policies that allow for enrollment of individuals at different points of their recovery.
Agencies that did not participate in FY 23-24 may complete. Submit compliant admission policy deliverable for approval by 10/30/24.
R95 Discharge Policy (2-B) – only for agencies that DID NOT participate in FY23-24
Designed to ensure more flexible discharge policies that do not result in automatic discharge if clients use substances during a treatment episode and facilitate a culture of treating SUDs as chronic conditions.
Agencies that did not participate in FY 23-24 may complete. Submit compliant discharge policy deliverable for approval by 10/30/24.
R95 Training Presentation (2-C) – only for agencies that DID NOT participate in FY23-24
Development of training for agency staff to ensure understanding and adoption of lower barrier care changes in admission policies (2-A), discharge policies (2-B) and toxicology (2-E).
Agencies that did not participate in FY 23-24 may complete. Submit compliant training presentation for approval by deliverable date: 11/30/24.
R95 Admission Agreement (2-D)
To ensure that patient-facing admission agreement aligns with the updated R95 admission and discharge policies and that current and prospective patients experience how the provider has embraced and actualized lower barrier care.
Any agency that has satisfied pre-requisites (R95 Admission Policy (2-A), R95 Discharge Policy (2-B) and R95 Training Presentation (2-C) may participate in new effort automatically).
Submit compliant admission agreement deliverable for approval by 12/31/24.
R95 Toxicology Policy and Patient Agreement (2-E)
To ensure that patient-facing toxicology agreement aligns with the updated R95 admission and discharge policies and that current and prospective patients experience how the provider has embraced and actualized
lower barrier care. Any agency that has satisfied pre-requisites (R95 Admission Policy (2-A),
R95 Discharge Policy (2-B) and R95 Training Presentation (2-C)) may participate in new effort automatically)
Submit compliant toxicology policy and patient agreement for approval by deliverable due date of 12/31/24.
R95 Staff Training Verification (2-F)
To ensure that managers and staff understand and effectively implement their updated policies and agreements, and what is expected of them as it relates to patients with minimum 85% participation in training.
Any agency that has satisfied pre-requisites (R95 Admission Policy (2-A), R95 Discharge Policy (2-B) and R95 Training Presentation (2-C) may participate in new effort automatically).
Submit verifications: A) Attestation of R95 Training Protocols for Staff and B) Verification of (minimum 85%) practitioner training participation between 7/1/24 and deliverable due date of 3/31/25.